☰

Dita Gratzinger, Ph.D. - Publications

Institution:
Yale University, New Haven, CT
Tree Info Grants Similar researchers PubMed Report error

48 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Aguilar-Navarro AG, Meza-León B, Gratzinger D, Juárez-Aguilar FG, Chang Q, Ornatsky O, Tsui H, Esquivel-Gómez R, Hernández-Ramírez A, Xie SZ, Dick JE, Flores-Figueroa E. Human Aging Alters the Spatial Organization between CD34+ Hematopoietic Cells and Adipocytes in Bone Marrow. Stem Cell Reports. PMID 32649902 DOI: 10.1016/J.Stemcr.2020.06.011  0.315
2020 Gupta S, Long SR, Natkunam Y, Kong CS, Gupta NK, Gratzinger D. Role of FNA with core biopsy or cell block in patients with nodular lymphocyte-predominant Hodgkin lymphoma. Cancer Cytopathology. PMID 32343479 DOI: 10.1002/Cncy.22286  0.339
2020 Ferreira CR, Manohar V, Zhao S, Bangs CD, Cherry A, Azevedo RS, Lage LAPC, Pereira J, Zerbini MCN, Gratzinger D, Natkunam Y. Genetic Subtypes of Systemic Anaplastic Large Cell Lymphoma Show Distinct Differences in PD-L1 Expression and Regulatory and Cytotoxic T Cells in the Tumor Microenvironment. Applied Immunohistochemistry & Molecular Morphology : Aimm. 28: 10-16. PMID 31809310 DOI: 10.1097/Pai.0000000000000798  0.321
2019 Ferreira CR, Zhao S, Sanches JA, Miyashiro D, Cury-Martins J, Azevedo RS, Zerbini MCN, Natkunam Y, Gratzinger D. Clinicopathologic and microenvironmental analysis of primary cutaneous CD30-positive lymphoproliferative disorders: a 26 year experience from an academic medical center in Brazil. Diagnostic Pathology. 14: 115. PMID 31640798 DOI: 10.1186/S13000-019-0900-7  0.325
2019 Manohar V, Peerani R, Tan B, Gratzinger D, Natkunam Y. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Positivity in Primary Follicles: Potential Pitfall in the Differential Diagnosis With Marginal Zone Lymphoma. Applied Immunohistochemistry & Molecular Morphology : Aimm. PMID 30640752 DOI: 10.1097/Pai.0000000000000738  0.381
2019 Kumar J, Scott G, Oak J, Raess P, Gratzinger D. Flow Cytometry Signature for Kikuchi-Fujimoto/Lupus Lymphadenitis Derived From 975 Benign and Malignant Lymphadenopathies American Journal of Clinical Pathology. 152: S105-S106. DOI: 10.1093/Ajcp/Aqz121.004  0.375
2018 Natkunam Y, Gratzinger D, Chadburn A, Goodlad JR, Chan JKC, Said J, Jaffe ES, de Jong D. Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal? Blood. PMID 30082493 DOI: 10.1182/Blood-2018-04-842559  0.349
2018 Gars E, Purington N, Scott G, Chisholm K, Gratzinger D, Martin BA, Ohgami RS. Bone marrow histomorphologic criteria can accurately diagnose hemophagocytic lymphohistiocytosis. Haematologica. PMID 29903767 DOI: 10.3324/Haematol.2017.186627  0.338
2018 Lezama LS, Gratzinger D. Nodal Involvement by CD30+ Cutaneous Lymphoproliferative Disorders and Its Challenging Differentiation From Classical Hodgkin Lymphoma. Archives of Pathology & Laboratory Medicine. 142: 139-142. PMID 29257929 DOI: 10.5858/Arpa.2016-0352-Rs  0.384
2017 de Jong D, Roemer MG, Chan JK, Goodlad J, Gratzinger D, Chadburn A, Jaffe ES, Said J, Natkunam Y. B-Cell and Classical Hodgkin Lymphomas Associated With Immunodeficiency: 2015 SH/EAHP Workshop Report-Part 2. American Journal of Clinical Pathology. 147: 153-170. PMID 28395108 DOI: 10.1093/Ajcp/Aqw216  0.358
2017 Natkunam Y, Goodlad JR, Chadburn A, de Jong D, Gratzinger D, Chan JK, Said J, Jaffe ES. EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1. American Journal of Clinical Pathology. 147: 129-152. PMID 28395107 DOI: 10.1093/Ajcp/Aqw214  0.348
2017 Gratzinger D, de Jong D, Jaffe ES, Chadburn A, Chan JK, Goodlad JR, Said J, Natkunam Y. T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4. American Journal of Clinical Pathology. 147: 188-203. PMID 28395105 DOI: 10.1093/Ajcp/Aqw213  0.317
2016 Gars E, Yousry SM, Babu D, Kurzer JH, George TI, Gratzinger D. A replicable CD271+ mesenchymal stromal cell density score: bringing the dysfunctional myelodysplastic syndrome niche to the diagnostic laboratory. Leukemia & Lymphoma. 1-3. PMID 27808583 DOI: 10.1016/J.Exphem.2016.06.137  0.329
2016 Jonas BA, Johnson C, Gratzinger D, Majeti R. Alkylator-Induced and Patient-Derived Xenograft Mouse Models of Therapy-Related Myeloid Neoplasms Model Clinical Disease and Suggest the Presence of Multiple Cell Subpopulations with Leukemia Stem Cell Activity. Plos One. 11: e0159189. PMID 27428079 DOI: 10.1371/Journal.Pone.0159189  0.324
2016 Matthews JM, Bhatt S, Patricelli MP, Nomanbhoy TK, Jiang X, Natkunam Y, Gentles AJ, Martinez E, Zhu D, Chapman JR, Cortizas E, Shyam R, Chinichian S, Advani R, Tan L, ... ... Gratzinger D, et al. Pathophysiological significance and therapeutic targeting of germinal center kinase in diffuse large B-cell lymphoma. Blood. PMID 27151888 DOI: 10.1182/Blood-2016-02-696856  0.37
2016 Fernandez-Pol S, Bangs CD, Cherry A, Arber DA, Gratzinger D. Two cases of histiocytic sarcoma with BCL2 translocations and occult or subsequent follicular lymphoma. Human Pathology. PMID 27134111 DOI: 10.1016/J.Humpath.2016.04.004  0.351
2016 Flores-Figueroa E, Gratzinger D. Beyond the Niche: Myelodysplastic Syndrome Topobiology in the Laboratory and in the Clinic. International Journal of Molecular Sciences. 17. PMID 27089321 DOI: 10.3390/Ijms17040553  0.302
2016 Gratzinger D, Jaffe ES. Mucocutaneous ulcer: a mimic of EBV + diffuse large B cell lymphoma in the immunodeficiency setting. Leukemia & Lymphoma. 1-2. PMID 27071493 DOI: 10.3109/10428194.2016.1166492  0.323
2016 Nybakken GE, Bala R, Gratzinger D, Jones CD, Zehnder JL, Bangs CD, Cherry A, Warnke RA, Natkunam Y. Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications. Plos One. 11: e0151735. PMID 26991267 DOI: 10.1371/Journal.Pone.0151735  0.365
2015 Gratzinger D, Million L, Kim YH. Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma. The American Journal of Dermatopathology. 37: 767-70. PMID 26381026 DOI: 10.1097/Dad.0000000000000377  0.358
2015 Ozawa MG, Ewalt MD, Gratzinger D. Dasatinib-related Follicular Hyperplasia: An Underrecognized Entity With Characteristic Morphology. The American Journal of Surgical Pathology. 39: 1363-9. PMID 26360368 DOI: 10.1097/Pas.0000000000000488  0.359
2015 Ungewickell A, Bhaduri A, Rios E, Reuter J, Lee CS, Mah A, Zehnder A, Ohgami R, Kulkarni S, Armstrong R, Weng WK, Gratzinger D, Tavallaee M, Rook A, Snyder M, et al. Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2. Nature Genetics. PMID 26258847 DOI: 10.1038/Ng.3370  0.348
2015 LeBlanc RE, Lefterova MI, Suarez CJ, Tavallaee M, Kim YH, Schrijver I, Kim J, Gratzinger D. Lymph node involvement by mycosis fungoides and Sézary syndrome mimicking angioimmunoblastic T-cell lymphoma. Human Pathology. 46: 1382-9. PMID 26193796 DOI: 10.1016/J.Humpath.2015.05.024  0.39
2014 Johnson RC, Kurzer JH, Greenberg PL, Gratzinger D. Mesenchymal stromal cell density is increased in higher grade myelodysplastic syndromes and independently predicts survival. American Journal of Clinical Pathology. 142: 795-802. PMID 25389333 DOI: 10.1309/Ajcp71Ophkotlsug  0.35
2014 Samols MA, Su A, Ra S, Cappel MA, Louissant A, Knudson RA, Ketterling RP, Said J, Binder S, Harris NL, Feldman AL, Kim J, Kim YH, Gratzinger D. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders. The American Journal of Surgical Pathology. 38: 1203-11. PMID 24805854 DOI: 10.1097/Pas.0000000000000217  0.419
2014 Ewalt MD, Gratzinger D. Classical Endothelial Markers Fail to Highlight Bone Marrow Sinusoids in the Marrow of Healthy Patients and Patients with Myelodysplastic Syndromes Blood. 124: 4170-4170. DOI: 10.1182/Blood.V124.21.4170.4170  0.347
2014 Reinisch A, Gratzinger D, Hong W, Majeti R. A Novel Humanized Bone Marrow Niche Xenotransplantation Model Allows Superior Engraftment of Human Normal and Malignant Hematopoietic Cells and Reveals Myelofibrosis-Initiating Cells in the HSC Compartment Blood. 124: 349-349. DOI: 10.1182/Blood.V124.21.349.349  0.357
2013 Gratzinger D, Greenberg PL. Update on Myelodysplastic Syndromes Classification and Prognosis. Surgical Pathology Clinics. 6: 693-728. PMID 26839194 DOI: 10.1016/J.Path.2013.08.005  0.319
2013 Metcalf RA, Bashey S, Wysong A, Kim J, Kim YH, Gratzinger D. Intravascular ALK-negative anaplastic large cell lymphoma with localized cutaneous involvement and an indolent clinical course: toward recognition of a distinct clinicopathologic entity. The American Journal of Surgical Pathology. 37: 617-23. PMID 23480896 DOI: 10.1097/Pas.0B013E318280Aa9C  0.384
2013 Matthews JM, Tan L, Bhatt S, Patricelli M, Nomanbhoy T, Zhang J, Jiang X, Natkunam Y, Choi HG, Gentles AJ, Martinez E, Zhu D, Chapman JR, Shyam RM, Chinichian S, ... ... Gratzinger D, et al. Germinal Center Kinase Regulates The Proliferation and Survival Of Diffuse Large B-Cell Lymphoma Blood. 122: 643-643. DOI: 10.1182/Blood.V122.21.643.643  0.374
2013 Johnson RC, Greenberg PL, Gratzinger D. CD271+ Mesenchymal Stromal Cell Density Is High In Poor-Risk MDS and Independently Predicts Overall Survival Blood. 122: 1560-1560. DOI: 10.1182/Blood.V122.21.1560.1560  0.329
2012 Flores-Figueroa E, Varma S, Montgomery K, Greenberg PL, Gratzinger D. Distinctive contact between CD34+ hematopoietic progenitors and CXCL12+ CD271+ mesenchymal stromal cells in benign and myelodysplastic bone marrow. Laboratory Investigation; a Journal of Technical Methods and Pathology. 92: 1330-41. PMID 22710983 DOI: 10.1038/Labinvest.2012.93  0.332
2012 Kim YH, Gratzinger D, Harrison C, Brody JD, Czerwinski DK, Ai WZ, Morales A, Abdulla F, Xing L, Navi D, Tibshirani RJ, Advani RH, Lingala B, Shah S, Hoppe RT, et al. In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: A phase 1/2 study Blood. 119: 355-363. PMID 22045986 DOI: 10.1182/Blood-2011-05-355222  0.336
2011 Flores-Figueroa E, Varma S, Montgomery K, Greenberg PL, Gratzinger D. Increased CD271+ CXCL12 Chemokine Overproducing Mesenchymal Stromal Cells Maintain Distinctive Association with CD34+ Hematopoietic Progenitor/Stem Cells in Myelodysplastic Syndrome Blood. 118: 2789-2789. DOI: 10.1182/Blood.V118.21.2789.2789  0.346
2010 Luo RF, Zhao S, Tibshirani R, Myklebust JH, Sanyal M, Fernandez R, Gratzinger D, Marinelli RJ, Lu ZS, Wong A, Levy R, Levy S, Natkunam Y. CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas. Human Pathology. 41: 271-80. PMID 20004001 DOI: 10.1016/J.Humpath.2009.07.022  0.388
2010 Gratzinger D, Advani R, Zhao S, Talreja N, Tibshirani RJ, Shyam R, Horning S, Sehn LH, Farinha P, Briones J, Lossos IS, Gascoyne RD, Natkunam Y. Lymphoma cell VEGFR2 expression detected by immunohistochemistry predicts poor overall survival in diffuse large B cell lymphoma treated with immunochemotherapy (R-CHOP). British Journal of Haematology. 148: 235-44. PMID 19821819 DOI: 10.1111/J.1365-2141.2009.07942.X  0.379
2010 Kim YH, Gratzinger D, Harrison C, Brody J, Czerwinski D, Xing L, Morales A, Ai W, Abdulla F, Navi D, Tibshirani RJ, Advani R, Natkunam Y, Hoppe RT, Levy R. In Situ Vaccination with TLR9 Agonist Combined with Local Radiation In Mycosis Fungoides: Analysis of Phase I/II Study Blood. 116: 286-286. DOI: 10.1182/Blood.V116.21.286.286  0.317
2010 Gratzinger D, Odegaard JI, Marinelli RJ, Sridhar KJ, Greenberg PL. In Situ Tissue Microarray Cell-Lineage Specific Analysis of Protein Expression In Intact Myelodysplastic Bone Marrow: Data on Putative Poor Prognosis Biomarkers Blood. 116: 1887-1887. DOI: 10.1182/Blood.V116.21.1887.1887  0.361
2009 Gratzinger D, Advani R, Zhao S, Talreja N, Tibshirani RJ, Horning SJ, Levy R, Lossos IS, Gascoyne RD, Natkunam Y. Prognostic significance of vascular endothelial growth factor (VEGF), VEGF receptors (VEGFR), and vascularity in diffuse large B-cell lymphoma treated with immunochemotherapy (R-CHOP). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 8581. PMID 27962266 DOI: 10.1200/Jco.2009.27.15_Suppl.8581  0.344
2009 Gratzinger D, Zhao S, West R, Rouse RV, Vogel H, Gil EC, Levy R, Lossos IS, Natkunam Y. The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities. American Journal of Clinical Pathology. 131: 264-78. PMID 19141387 DOI: 10.1309/Ajcp5Fp3Naxaxrje  0.352
2008 Natkunam Y, Farinha P, Hsi ED, Hans CP, Tibshirani R, Sehn LH, Connors JM, Gratzinger D, Rosado M, Zhao S, Pohlman B, Wongchaowart N, Bast M, Avigdor A, Schiby G, et al. LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 447-54. PMID 18086797 DOI: 10.1200/Jco.2007.13.0690  0.341
2008 Gratzinger D, Zhao S, Tibshirani RJ, Hsi ED, Hans CP, Pohlman B, Bast M, Avigdor A, Schiby G, Nagler A, Byrne GE, Lossos IS, Natkunam Y. Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapy. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 38-47. PMID 17998899 DOI: 10.1182/Blood.V110.11.53.53  0.366
2008 Gratzinger D, Zhao S, Ai W, Tibshirani R, Levy R, Natkunam Y. Lymphoma-Expressed VEGF-a, VEGFR-1, VEGFR-2, and Microvessel Density Are Not Predictive of Overall Survival in Follicular Lymphoma Blood. 112: 3767-3767. DOI: 10.1182/Blood.V112.11.3767.3767  0.386
2007 Gratzinger D, Zhao S, Marinelli RJ, Kapp AV, Tibshirani RJ, Hammer AS, Hamilton-Dutoit S, Natkunam Y. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes. The American Journal of Pathology. 170: 1362-9. PMID 17392174 DOI: 10.2353/Ajpath.2007.060901  0.36
2005 Biswas P, Zhang J, Schoenfeld JD, Schoenfeld D, Gratzinger D, Canosa S, Madri JA. Identification of the regions of PECAM-1 involved in beta- and gamma-catenin associations. Biochemical and Biophysical Research Communications. 329: 1225-33. PMID 15766557 DOI: 10.1016/J.Bbrc.2005.02.095  0.474
2003 Gratzinger D, Canosa S, Engelhardt B, Madri JA. Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 17: 1458-69. PMID 12890700 DOI: 10.1096/Fj.02-1040Com  0.535
2003 Enciso JM, Gratzinger D, Camenisch TD, Canosa S, Pinter E, Madri JA. Elevated glucose inhibits VEGF-A-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. The Journal of Cell Biology. 160: 605-15. PMID 12591918 DOI: 10.1083/Jcb.200209014  0.511
2003 Gratzinger D, Barreuther M, Madri JA. Platelet-endothelial cell adhesion molecule-1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif. Biochemical and Biophysical Research Communications. 301: 243-9. PMID 12535670 DOI: 10.1016/S0006-291X(02)02982-0  0.538
Show low-probability matches.